NanoVibronix, Inc. (NAOV) Financials

NAOV Assets vs Liabilities

DateAssetsLiabilities
Sept. 30, 2024 4.7 million 2.8 million
June 30, 2024 5.7 million 2.9 million
March 31, 2024 6.2 million 2.7 million
Dec. 31, 2023 6.7 million 2.7 million

NAOV Free Cash Flow and Stock based compensation

Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
Sept. 30, 2024 -836000 58000
June 30, 2024 -555000 28000
March 31, 2024 -580000 107000
Dec. 31, 2023 -491000 124000

NAOV Net Income

No data available :(

NAOV Cash and Debt

Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
Sept. 30, 2024 1.3 million 77000 77000
June 30, 2024 2.2 million 89000 133000
March 31, 2024 2.7 million 86000 110000
Dec. 31, 2023 3.3 million - 5000

NAOV Shares Outstanding

Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
Sept. 30, 2024 2.8 million
June 30, 2024 2.8 million
March 31, 2024 2.5 million
Dec. 31, 2023 2.0 million

NAOV Expenses

Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
Sept. 30, 2024 - 249000 854000 181000
June 30, 2024 2000 187000 915000 199000
March 31, 2024 1000 121000 1.1 million 165000
Dec. 31, 2023 - 62000 1.4 million 233000

NAOV Cost of Revenue

Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
Sept. 30, 2024 376000 243000
June 30, 2024 817000 389000
March 31, 2024 921000 257000
Dec. 31, 2023 1.2 million 440000

NAOV

Price: $1.90

52 week price:
1.05
162.50

Earnings Per Share: -51.81 USD

P/E Ratio: -0.04

Exchange: NCM

Sector: Healthcare

Industry: Medical Devices

Country: United States

Volume: 84500

Market Capitalization: 1.6 million

Links: